Natural Killer Cells Therapeutics Market is expected to grow at a CAGR of 11.83% 2031
The increasing prevalence of chronic diseases, such as cancer, is expected to drive growth in the global natural killer cell therapeutics market over the forecast period, 2027-2031.
According to
TechSci Research report, “Natural killer
Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2021-2031”, the global Natural Killer Cells Therapeutics Market will grow from USD 451.05 Million in 2025 to USD 882.22 Million by 2031 at a 11.83% CAGR. This can be ascribed to the rising aging population susceptible to various
chronic diseases such as heart disease, arthritis, diabetes, stroke, cancer,
among others. Besides, changing lifestyle patterns, adoption of a sedentary lifestyle, and unhealthy eating habits, among others, are further contributing towards different diseases requiring an effective and permanent treatment. This has prompted the research community worldwide to shift its focus to developing effective treatments for these diseases and identifying the most effective curative option. This, in turn, is expected to create lucrative opportunities for the growth of new treatment options, such as natural killer therapeutics market, over the coming few years.
However, lack of specificity and
poor in-vivo survival of the natural killer cells may hamper the market growth.
Similarly, lack of specificity among natural killer cells leads to targeting
the wrong cells thereby making the treatment ineffective thereby restricting
the market growth. Moreover, limited awareness and affordability constraints, particularly in emerging economies, can further slow the growth of the global natural killer cell therapeutics market.
Browse over XX market data Figures spread through 110 Pages and an in-depth
TOC on "Natural Killer Cells Therapeutics Market"
The global natural killer cells therapeutics market can be segmented by type, by application, by end user and by region.
Based on application, the global natural killer cell therapeutics market can be segmented into cancer, gastrointestinal diseases, immunoproliferative disorders, and other indications. The cancer application is expected to
dominate the market during the forecast period. This can be attributed to the
growing prevalence of different forms of cancers worldwide. Additionally, an increase in the adoption of natural killer cell therapies for the treatment of various types of cancers, such as acute myeloid leukemia, Hodgkin’s lymphoma, hematologic malignancies, solid tumors, cutaneous T cell lymphoma, and head and neck cancer, is expected to support the segmental growth and overall natural killer cell therapeutics market.
By end user, the global natural killer cell therapeutics market can be segmented into hospitals & clinics, academic
& research institutions, and others. The academic and research institute segment
is predicted to dominate the market in the forecast period. This can be ascribed to the growing research & development activities conducted by these organizations to develop an effective natural killer cell therapeutic solution for the treatment of different diseases.
Major
companies operating in global natural killer cells therapeutics market are:
- Affimed N.V.
- Century Therapeutics, Inc.
- Celularity Inc.
- Cytovac A/S
- Dragonfly Therapeutics, Inc.
- Fate Therapeutics, Inc.
- Gamida Cell Ltd.
- ImmunityBio, Inc.
- Innate Pharma SA
- Nkarta, Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- VaxCell Biotherapeutics Co., Ltd.
- Acepodia Inc.
- Glycostem Therapeutics B.V.
Download Free Sample Report
Customers may also request 10% free customization of this report.
North America is expected to dominate the global natural killer cell therapeutics market due to the region's growing cancer prevalence. Additionally, increasing research & development activities in the region for the development of natural killer cells therapeutics, especially in the United States, is expected to create lucrative opportunities for the market growth in the coming years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region 2021-2031F”, has evaluated the future growth potential of
global natural killer cells therapeutics market and provides statistics &
information on market size, structure, and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global natural killer cells therapeutics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com